Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid.

[1]  L. Treccani,et al.  Utilizing the protein corona around silica nanoparticles for dual drug loading and release. , 2015, Nanoscale.

[2]  M. Valle,et al.  Lipidic nanovesicles stabilize suspensions of metal oxide nanoparticles. , 2015, Chemistry and physics of lipids.

[3]  H. Boulaiz,et al.  Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules. , 2015, Biomaterials.

[4]  Giulio Caracciolo,et al.  Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[5]  B. Forbes,et al.  What are the biological and therapeutic implications of biomolecule corona formation on the surface of inhaled nanomedicines? , 2015, Nanomedicine.

[6]  M. Kendall,et al.  Nanoparticle growth and surface chemistry changes in cell-conditioned culture medium , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[7]  Xiaoxiao Cai,et al.  Enhanced biostability of nanoparticle-based drug delivery systems by albumin corona. , 2015, Nanomedicine.

[8]  C. Ruppert,et al.  Biophysical inhibition of pulmonary surfactant function by polymeric nanoparticles: role of surfactant protein B and C. , 2014, Acta biomaterialia.

[9]  K. Landfester,et al.  Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface. , 2014, Colloids and surfaces. B, Biointerfaces.

[10]  L. Que,et al.  Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help? , 2014, American journal of respiratory cell and molecular biology.

[11]  B. Forbes,et al.  Lost in translation: what is stopping inhaled nanomedicines from realizing their potential? , 2014, Therapeutic delivery.

[12]  D. Goodlett,et al.  Shotgun MS proteomic analysis of bronchoalveolar lavage fluid in normal subjects , 2014, Proteomics. Clinical applications.

[13]  E. Brun,et al.  Could nanoparticle corona characterization help for biological consequence prediction? , 2014, Cancer Nanotechnology.

[14]  B. Forbes,et al.  Quantitative assessment of nanoparticle surface hydrophobicity and its influence on pulmonary biocompatibility. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[15]  T. Thatcher,et al.  Cigarette Smoke Exposure Exacerbates Lung Inflammation and Compromises Immunity to Bacterial Infection , 2014, The Journal of Immunology.

[16]  Nathan A. Baker,et al.  Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[18]  Fengjuan Wang,et al.  The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[19]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[20]  W. Kreyling,et al.  Pulmonary surfactant is indispensable in order to simulate the in vivo situation , 2013, Particle and Fibre Toxicology.

[21]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[22]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[23]  J. Kah,et al.  Exploiting the protein corona around gold nanorods for loading and triggered release. , 2012, ACS nano.

[24]  Kenneth A. Dawson,et al.  Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. , 2012, ACS nano.

[25]  Iseult Lynch,et al.  Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Peter Wick,et al.  Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro , 2012, Particle and Fibre Toxicology.

[27]  E. Vogler,et al.  Protein adsorption in three dimensions. , 2012, Biomaterials.

[28]  C. Casals,et al.  Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[29]  Claus-Michael Lehr,et al.  Interaction of metal oxide nanoparticles with lung surfactant protein A. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[31]  Dominique Lison,et al.  The nanosilica hazard: another variable entity , 2010, Particle and Fibre Toxicology.

[32]  Wolfgang G Kreyling,et al.  Nanoparticles in the lung , 2010, Nature Biotechnology.

[33]  Roberto Cingolani,et al.  Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.

[34]  D. Hourcade,et al.  Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces* , 2010, The Journal of Biological Chemistry.

[35]  Hak Soo Choi,et al.  Rapid translocation of nanoparticles from the lung airspaces to the body , 2010, Nature Biotechnology.

[36]  F. Kelly,et al.  Proinflammatory doses of diesel exhaust in healthy subjects fail to elicit equivalent or augmented airway inflammation in subjects with asthma , 2010, Thorax.

[37]  V. Puntes,et al.  Time evolution of the nanoparticle protein corona. , 2010, ACS nano.

[38]  Sara Linse,et al.  Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid , 2010, PloS one.

[39]  H. Craig-Barnes,et al.  Surfactant Protein D Interacts with α2-Macroglobulin and Increases Its Innate Immune Potential* , 2010, The Journal of Biological Chemistry.

[40]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[41]  J. Hohlfeld,et al.  Interaction of nanoparticles with the pulmonary surfactant system , 2009, Inhalation toxicology.

[42]  Parag Aggarwal,et al.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.

[43]  M. O. Gul,et al.  A poly(vinyl alcohol) nanoparticle platform for kinetic studies of inhaled particles , 2009, Inhalation toxicology.

[44]  D. Waisman,et al.  Nanostructure of the aqueous form of lung surfactant of different species visualized by cryo‐transmission electron microscopy , 2007, Clinical physiology and functional imaging.

[45]  D. Traini,et al.  The nanoscale in pulmonary delivery. Part 2: formulation platforms , 2007, Expert opinion on drug delivery.

[46]  D. Traini,et al.  The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects , 2007, Expert opinion on drug delivery.

[47]  Xiaomei Mu,et al.  Preparation and properties of poly(vinyl alcohol)-stabilized liposomes. , 2006, International journal of pharmaceutics.

[48]  J. Pérez-Gil,et al.  Protein-lipid interactions and surface activity in the pulmonary surfactant system. , 2006, Chemistry and physics of lipids.

[49]  J. Whitsett,et al.  In defense of the lung: surfactant protein A and surfactant protein D. , 2006, Current opinion in pharmacology.

[50]  M. Kamran,et al.  Surfactant proteins SP-A and SP-D: structure, function and receptors. , 2006, Molecular immunology.

[51]  Stephen J. Callister,et al.  Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. , 2006, Journal of proteome research.

[52]  E. Pozzi,et al.  SP-A binds alpha1-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase , 2005, Respiratory research.

[53]  James P. Malone,et al.  Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid*S , 2005, Molecular & Cellular Proteomics.

[54]  G. Anantharamaiah,et al.  D-4F, an Apolipoprotein A-I Mimetic Peptide, Inhibits the Inflammatory Response Induced by Influenza A Infection of Human Type II Pneumocytes , 2004, Circulation.

[55]  N. Pattabiraman,et al.  Uteroglobin Represses Allergen-induced Inflammatory Response by Blocking PGD2 Receptor–mediated Functions , 2004, The Journal of experimental medicine.

[56]  M. Lippmann,et al.  Urban PM2.5 Surface Chemistry and Interactions with Bronchoalveolar Lavage Fluid , 2004, Inhalation toxicology.

[57]  W. Watford,et al.  Surfactant protein A enhances the phagocytosis of C1q-coated particles by alveolar macrophages. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[58]  Alexey I Nesvizhskii,et al.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.

[59]  K. Edwards,et al.  Cryo transmission electron microscopy of liposomes and related structures , 2000 .

[60]  W. Dobryszycka,et al.  Biological functions of haptoglobin--new pieces to an old puzzle. , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[61]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[62]  R. Oosting,et al.  Characterization of the surfactant protein A receptor: cell and ligand specificity. , 1994, The American journal of physiology.

[63]  Y. Fujiyoshi,et al.  A new method to measure bilayer thickness: cryo-electron microscopy of frozen hydrated liposomes and image simulation. , 1994, Micron.

[64]  R. Mackay,et al.  University of Birmingham Nanoparticles modulate surfactant protein A and D mediated protection against influenza A infection in vitro , 2014 .

[65]  M. Nieuwenhuijsen,et al.  Lung lining liquid modifies PM(2.5) in favor of particle aggregation: a protective mechanism. , 2002, American journal of physiology. Lung cellular and molecular physiology.